The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

被引：0
|
作者：
Kristina S. Boye
Hélène Sapin
Luis-Emilio García-Pérez
Myriam Rosilio
Marco Orsini Federici
Elke Heitmann
Heike Jung
Ulrich Aigner
Bruno Guerci
Francesco Giorgino
Kirsi Norrbacka
机构：
[1] Eli Lilly and Company,
[2] Lilly France SAS,undefined
[3] Lilly S.A.,undefined
[4] Eli Lilly and Company,undefined
[5] Lilly Deutschland GmbH,undefined
[6] Versdias GmbH,undefined
[7] University Hospital of Nancy,undefined
[8] University of Bari Aldo Moro,undefined
[9] Eli Lilly and Company,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Dulaglutide; Glucagon-like peptide 1 receptor agonists; Liraglutide; Patient-reported outcomes; Real-world study; Type 2 diabetes patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2383 / 2399
页数：16
相关论文
共 50 条
  • [31] Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study
    Anderson, John
    Soteres, Daniel
    Mellor, Jennifer
    Connolly, Hannah
    Chem, M.
    Wynne-Cattanach, Kieran
    Earl, Lucy
    Schultz, Bob G.
    Juethner, Salome
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (04) : 247 - 254
  • [32] The INITIATOR study: real-world treatment patterns and outcomes in patients with type 2 diabetes initiating insulin glargine or liraglutide
    Levin, P. A.
    Wei, W.
    Buysman, E.
    Thayer, S.
    Brekke, L.
    Crown, W. H.
    Grabner, M.
    Ke, X.
    Quimbo, R. A.
    Cziraky, M. J.
    Hu, W.
    Cuddihy, R.
    Chu, J. W.
    [J]. DIABETOLOGIA, 2014, 57 : S53 - S54
  • [33] Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
    Yabe, Daisuke
    Higashiyama, Hiroko
    Kadowaki, Takashi
    Origasa, Hideki
    Shimomura, Iichiro
    Watada, Hirotaka
    Tobe, Keisuke
    Iglay, Kristy
    Tokita, Shigeru
    Seino, Yutaka
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
  • [34] Effects of Dulaglutide on Renal Function, Glycemic Control, and Weight Outcomes in Indian Patients with Type 2 Diabetes: A Real-World Study
    Patange, Sonali A.
    [J]. DIABETES, 2019, 68
  • [35] PATIENT-REPORTED OUTCOMES OF A PROSPECTIVE STUDY OF ENDOMETRIOSIS PATIENTS
    Courtright, Laura
    Singh, Bhuchitra
    Brennan, Joshua T.
    Chen, Lucy Xi
    Wu, Harold Y.
    Patzkowsky, Kristin E.
    Wang, Karen
    Simpson, Khara
    Wang, Tian-Li
    Cope, Leslie
    Schepisi, Lisa
    Taylor, Hugh S.
    Segars, James H.
    [J]. FERTILITY AND STERILITY, 2023, 120 (04) : E61 - E61
  • [36] XERMELO Patient Registry: A Real-World Evidence Study Evaluating Patient-Reported Outcomes With XERMELO
    Joish, Vijay N.
    Price, Mark A.
    Schwartz, Steven
    Stanley, Shanna
    Bennett, Lee
    Darden, Christina
    Tesfaye, Eshetu
    Mobley, Quintella
    Arnold, Karie
    Wason, Suman
    Lapuerta, Pablo
    [J]. PANCREAS, 2019, 48 (03) : 439 - 439
  • [37] Are real-world patient-reported outcomes associated with survival in patients with advanced pancreatic cancer?
    Dai, Wei Fang
    Beca, Jaclyn Marie
    Guo, Helen
    Qiao, Lucy
    Isaranuwatchai, Wanrudee
    Schwartz, Deborah
    Naipaul, Rohini
    Arias, Jessica
    Gavura, Scott
    Barbera, Lisa Catherine
    Chan, Kelvin K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [38] Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
    Suzuki, Shuichi
    Oura, Tomonori
    Takeuchi, Masakazu
    Boye, Kristina S.
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [39] Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
    Shuichi Suzuki
    Tomonori Oura
    Masakazu Takeuchi
    Kristina S. Boye
    [J]. Health and Quality of Life Outcomes, 15
  • [40] Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes
    Levin, Philip
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Lin, Jay
    Baser, Onur
    [J]. DIABETES, 2012, 61 : A4 - A4
12345